Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-β1 is a cell cycle-independent effect and influences their hematopoietic potential

Blood

Volumn 95, Issue 10, 2000, Pages 3001-3010

  Pierelli, Luca ^a   Marone, Maria ^a   Bonanno, Giuseppina ^a   Mozzetti, Simona ^a   Rutella, Sergio ^a   Morosetti, Roberta ^a   Rumi, Carlo ^a   Mancuso, Salvatore ^a   Leone, Giuseppe ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CELL CYCLE PROTEIN; ENDOGLIN; MYC PROTEIN; NEUTRALIZING ANTIBODY; PROTEIN BCL 2; PROTEIN P27; PROTEIN P53; TRANSCRIPTION FACTOR GATA 1; TRANSFORMING GROWTH FACTOR BETA1;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; GROWTH STIMULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0034657830     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.10.3001.009k34a_3001_3009     Document Type: Article

References (43)

1. Marcu KB, Bossone SA, Patel AJ. Myc function and regulation. Ann Rev Biochem. 1992;61:809.
2. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood. 1994;84:2391.
3. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol. 1994;124:1.
4. Sato N, Sakamaki K, Terada N, Arai K, Miyajima A. Signal transduction by the high-affinity GM-CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. EMBO J. 1993;12:4181.
5. Kinoshita T, Yokota T, Arai K, Miyajima A. Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors. EMBO J. 1995;14:266.
6. Deng G, Podack ER. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc Natl Acad Sci U S A. 1993;90:2189.
7. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA. The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci U S A. 1994;91:7553.
8. Marone M, Pierelli L, Mozzetti S, et al. High cdk inhibitors and p53 levels in Bcl-2 and Bcl-xL-expressing primitive proliferating hematopoietic progenitors. Exp Hematol. 1999;27(suppl 1):108.
9. Ryan JJ, Prochownik E, Gottlieb CA, et al. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc Natl Acad Sci U S A. 1994;91:5878.
10. Massague J. The transforming growth factor-β1 family. Annu Rev Cell Biol. 1990;6:597.
11. Pierelli L, Scambia G, Fattorossi A, et al. Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors. Br J Haematol. 1998; 102:1139.
12. Larocca LM, Teofili L, Sica S, et al. Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood. 1995;85:3654.
13. Pierelli L, Scambia G, Bonanno G, et al. Expansion of granulocyte colony-stimulating factor/ chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15. Exp Hematol. 1999;27:416.
14. Marone M, Scambia G, Mozzetti S, et al. Bcl-2, bax, bcl-xL and bcl-xS expression in normal and neoplastic ovarian tissues. Clin Cancer Res. 1998;4:517.
15. Whong H, Anderson WD, Cheng T, Riabowol KT. Monitoring mRNA expression by polymerase chain reaction by the 'primer dropping' method. Anal Biochem. 1994;223:251.
16. Chow WT, Queck HH, Tock EP. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line. Cancer Lett. 1993;73:141.
17. Morosetti R, Park DJ, Chumakov AM, et al. A novel, myeloid transcription factor, C/EBPε is upregulated during granulocytic, but not monocytic, differentiation. Blood. 1997;90:2591.
18. Park JR, Bernstein ID, Hockenbery DM. Primitive human hematopoietic precursors express bcl-x but not bcl-2. Blood. 1995;86:868.
19. Hatzfeld J, Li M-L, Brown EL, et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. J Exp Med. 1991;174: 925.
20. Eaves CJ, Cashman JD, Kay RJ, et al. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood. 1997;78:110.
21. Ohishi K, Katayama N, Itoh R, et al. Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta. Blood. 1996;87:1718.
22. Renysdottir I, Polyak K, Iavarone A, Massague J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev. 1995;9:1831.
23. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massague J. Growth inhibition by TGF-β1 linked to suppression of retinoblastoma protein phosphorylation. Cell. 1990;62:175.
24. Bang OS, Ruscetti FW, Lee MH, Kim SJ, Birchenall-Roberts MC. Transforming growth factor-beta1 modulates p107 function in myeloid cells: correlation with cell cycle progression. J Biol Chem. 1996;271:7811.
25. Dao MA, Taylor N, Nolta JA. Reduction in levels of the cyclin-dependent kinase inhibitor p27kip-1 coupled with transforming growth factor β neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc Natl Acad Sci U S A. 1998;95: 13,006.
26. Fortunel N, Batard P, Hatzfeld A, et al. High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells. J Cell Sci. 1998;111:1867.
27. Gleizes P-E, Munger JS, Nunes I, et al. TGF-β latency: biological significance and mechanism of activation. Stem Cells. 1997;15:190.
28. Prehn JHM, Bindokas VP, Marcuccilli CJ, Krajewski S, Reed JC, Miller RJ. Regulation of neuronal bcl-2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons. Proc Natl Acad Sci U S A. 1994;91:12,599.
29. Tomoda T, Shirasawa T, Yahagi Y-I, et al. Transforming growth factor-β is a survival factor for neonate cortical neurons: coincident expression of type I receptors in developing cerebral cortices. Dev Biol. 1996;179:79.
30. Mahmud N, Katayama N, Nishii K, et al. Possible involvement of bcl-2 in regulation of cell-cycle progression of haemopoietic cells by transforming growth factor-β1. Br J Haematol. 1999;105: 470.
31. Campos L, Sabido O, Rouault J-R, Guyotat D. Effects of bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood. 1994;84:595.
32. Weber-Nordt RM, Henschler R, Schott E, et al. Interleukin-10 increases bcl-2 expression and survival in primary human CD34+ hematopoietic progenitor cells. Blood, 1996;88:2549.
33. Polyak K, Kato J-Y, Solomon MJ, et al. p27kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev. 1994;8:9.
34. Ravitz MJ, Yan S, Herr KD, Wenner C. TGFβ-induced activation of cyclin E-cdk2 kinase and downregulation of p27kip1 in C3H10T1/2 mouse fibroblasts. Cancer Res. 1995; 55:1413.
35. Yaroslavskiy B, Watkins S, Donnenberg AD, Patton TJ, Steinman RA. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood. 1999;93:2907.
36. Wang QM, Jones JB, Studzinski GP. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res. 1996;56:264.
37. Dickson MC, Martin JS, Cousins FM, Kulkami AB, Karlsson S, Akhurst RJ. Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development. 1995;121:1845.
38. Shivdasani R, Orkin SH. The transcriptional control of hematopoiesis. Blood. 1996;87:4025.
39. Kuo ML, Chen CW, Jee SH, Chuang SE, Cheng AL. Transforming growth factor beta 1 attenuates ceramide-induced CPP32/Yama activation and apoptosis in human leukaemic HL-60 cells. Biochem J. 1997;327:663.
40. Saeki K, Yuo A, Kato M, Miyazono K, Yazaki Y, Takaku F. Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor beta1 and overexpression of bcl-2. J Biol Chem. 1997;272:20,003.
41. low/- precursors. Br J Haematol. In press.
42. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immunodeficient mice. Proc Natl Acad Sci U S A. 1997;94:5320.
43. Bhatia M, Bonnet D, Kapp U, Wang JCY, Murdoch B, Dick JE. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 1997;186:619.